当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析 - 资产负债表

科伦药业

(002422)

  

流通市值:449.75亿  总市值:550.37亿
流通股本:13.06亿   总股本:15.98亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金6,452,330,0336,032,284,8506,326,904,9875,788,951,250
  交易性金融资产1,815,478,9851,456,758,2591,508,578,1821,273,440,595
  应收票据及应收账款4,943,841,6194,673,225,0514,841,289,7095,035,731,238
        应收账款4,943,841,6194,673,225,0514,841,289,7095,035,731,238
  应收款项融资1,289,655,0431,334,186,292992,867,1471,177,632,847
  预付款项513,862,092431,737,560842,440,127442,839,122
  其他应收款合计122,017,70982,686,774109,378,742104,511,168
  其中:应收利息4,781,8454,730,8834,676,2094,918,024
        应收股利09,601,8778,523,036-
  存货3,792,786,2793,847,311,8053,463,037,7203,565,576,666
  其他流动资产2,354,944,1172,181,828,3582,420,655,8032,194,981,851
  流动资产合计21,284,915,87720,040,018,94920,505,152,41719,583,664,737
非流动资产:
  长期股权投资4,513,161,9514,464,937,2004,418,640,3274,295,038,918
  其他权益工具投资129,565,312130,424,617134,002,727133,922,810
  其他非流动金融资产46,516,78228,516,78230,000,00030,000,000
  固定资产10,972,547,95910,968,762,04110,768,840,29110,889,385,192
  在建工程1,534,160,0021,504,433,0471,579,764,5081,426,413,928
  使用权资产591,248,755600,507,032598,374,198612,554,726
  无形资产1,214,145,8211,226,104,1581,207,170,0941,231,637,348
  开发支出-01,000,0001,000,000
  商誉96,249,05696,249,05698,659,99498,659,994
  长期待摊费用92,061,58090,874,93862,931,57168,884,133
  递延所得税资产452,691,567455,253,463419,491,013414,892,701
  其他非流动资产214,545,548228,742,042280,271,288264,447,950
  非流动资产合计19,856,894,33319,794,804,37619,599,146,01119,466,837,700
  资产总计41,141,810,21039,834,823,32540,104,298,42839,050,502,437
流动负债:
  短期借款2,418,468,6752,556,965,6652,939,519,3303,178,689,126
  交易性金融负债901,1700226,400-
  应付票据及应付账款2,562,514,3902,532,510,6682,281,811,5102,327,079,176
  其中:应付票据239,177,754138,793,857191,964,685343,910,750
        应付账款2,323,336,6362,393,716,8112,089,846,8251,983,168,426
  合同负债490,648,651448,178,109392,416,825429,078,437
  应付职工薪酬353,622,369624,444,529479,196,711409,922,561
  应交税费233,305,751225,358,893259,754,707223,647,789
  其他应付款合计2,328,550,3981,867,867,3731,831,837,1371,699,812,964
  其中:应付利息-0--
        应付股利-0200,438,432-
  一年内到期的非流动负债656,340,614211,875,427453,765,562790,452,752
  其他流动负债1,021,778,076722,427,9441,519,234,56217,155,785
  流动负债合计10,066,130,0949,189,628,60810,157,762,7449,075,838,590
非流动负债:
  长期借款191,100,000191,100,000193,550,000193,550,000
  租赁负债528,297,063544,456,330534,121,311532,043,352
  预计负债5,265,6523,743,0232,824,4302,999,965
  递延收益316,540,410326,806,570318,784,455300,423,751
  递延所得税负债287,631,473285,195,131274,387,463280,640,763
  其他非流动负债-0--
  非流动负债合计1,328,834,5981,351,301,0541,323,667,6591,309,657,831
  负债合计11,394,964,69210,540,929,66211,481,430,40310,385,496,421
所有者权益(或股东权益):
  实收资本(或股本)1,598,053,3721,598,053,3721,598,053,3721,598,053,372
  资本公积8,794,960,6728,767,986,1218,741,790,8968,712,761,286
  减:库存股142,068,777131,701,776131,701,776131,701,776
  其他综合收益6,844,21863,559,61074,401,04174,364,528
  专项储备2,923,2952,826,3952,815,4022,873,300
  盈余公积1,743,693,0581,743,693,0581,620,121,2581,620,121,258
  未分配利润12,633,754,69212,180,053,98011,802,356,00211,802,754,073
  归属于母公司股东权益合计24,638,160,53024,224,470,76023,707,836,19523,679,226,041
  少数股东权益5,108,684,9885,069,422,9034,915,031,8304,985,779,975
  股东权益合计29,746,845,51829,293,893,66328,622,868,02528,665,006,016
  负债和股东权益合计41,141,810,21039,834,823,32540,104,298,42839,050,502,437
公告日期2026-04-292026-04-032025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑